Olanzapine
NDC Package 68258-7153-1

11-digit billing NDC: 68258715301

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Olanzapine is none with olanzapine monotherapy.When using olanzapine and fluoxetine in combination, also refer to the Contraindications section of the package insert for olanzapine and fluoxetine in combination.For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products. Marketed by Dispensing Solutions, Inc., this product is identified by NDC 68258-7153 and is authorized under FDA application ANDA076000.

Identification & Billing

NDC Package Code
68258-7153-1
Package Description
14 TABLET, FILM COATED in 1 BOTTLE
Product Code
11-Digit Billing Format
68258715301
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Olanzapine
Dosage Form
-
Usage Information
None with olanzapine monotherapy.When using olanzapine and fluoxetine in combination, also refer to the Contraindications section of the package insert for olanzapine and fluoxetine in combination.For specific information about the contraindications of lithium or valproate, refer to the Contraindications section of the package inserts for these other products.

Regulatory & Marketing

Labeler Name
Dispensing Solutions, Inc.
FDA Application #
ANDA076000
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
10-24-2011
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68258-7153-1 identifies a specific commercial package of 14 tablet, film coated in 1 bottle of Olanzapine, labeled by Dispensing Solutions, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dispensing Solutions, Inc. on October 24, 2011. The current certification is valid through December 31, 2017.

How is this Dispensing Solutions, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68258715301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68258-7153-1
11-Digit CMS (5-4-2)
68258-7153-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.